CIK 0000944809
- Accelerated filer
OPKO HEALTH, INC.
Sign in to watch- Ticker
- OPK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 752402409
- Phone
- +1 305-575-4181
- Business address
- 4400 BISCAYNE BLVD., MIAMI, FL, 33137
- Former names
- EXEGENICS INC, eXegenics Inc, CYTOCLONAL PHARMACEUTICS INC /DE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $24,577
- in 1 filing
Net −$24,577. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-05 | Nabel Gary J. Chief Innovation Officer | Purchase | +27,624 | $1.81 | $50K | 153,342 |
| 2023-05-05 | Nabel Gary J. Chief Innovation Officer | Purchase | +79,334 | $1.82 | $144K | 232,676 |
| 2023-05-05 | Nabel Gary J. Chief Innovation Officer | Purchase | +19,475 | $1.83 | $36K | 252,151 |
| 2023-05-05 | Nabel Gary J. Chief Innovation Officer | Purchase | +10,928 | $1.83 | $20K | 263,079 |
| 2023-05-05 | Nabel Gary J. Chief Innovation Officer | Purchase | +28,538 | $1.82 | $52K | 19,886,052 |
| 2023-05-05 | Nabel Gary J. Chief Innovation Officer | Purchase | +26,407 | $1.85 | $49K | 19,912,459 |
| 2023-05-05 | Nabel Gary J. Chief Innovation Officer | Purchase | +54,945 | $1.82 | $100K | 19,912,459 |
| 2023-05-05 | Nabel Gary J. Chief Innovation Officer | Purchase | +34,338 | $1.84 | $63K | 114,338 |
| 2023-05-05 | Nabel Gary J. Chief Innovation Officer | Purchase | +54,346 | $1.84 | $100K | 168,684 |
| 2023-05-05 | Nabel Gary J. Chief Innovation Officer | Purchase | +20,009 | $1.85 | $37K | 188,693 |
| 2023-05-05 | Nabel Gary J. Chief Innovation Officer | Purchase | +54,054 | $1.85 | $100K | 242,747 |
| 2023-03-22 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +700 | $1.31 | $917 | 199,832,394 |
| 2023-03-22 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +57,100 | $1.32 | $75K | 199,889,494 |
| 2023-03-22 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +25,200 | $1.32 | $33K | 199,914,694 |
| 2023-03-22 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +116,648 | $1.33 | $155K | 200,031,342 |
| 2023-03-22 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +352 | $1.33 | $468 | 200,031,694 |
| 2023-03-08 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +300 | $1.12 | $336 | 198,831,994 |
| 2023-03-08 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +39,028 | $1.13 | $44K | 198,871,022 |
| 2023-03-08 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +22,049 | $1.13 | $25K | 198,893,071 |
| 2023-03-08 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +5,700 | $1.13 | $6K | 198,898,771 |
Page 11 of 33 · 653 trades